drugset / Trial / NCT00206232
Novel Treatment for Diastolic Heart Failure in Women
RandomizedParallel-groupQuadruple-blindDiagnostic
Summary
The purpose of the study is to collect information about the potential benefit and safety of low dose spironolactone for a patient with diastolic heart failure (DHF) and to determine whether spironolactone can cause the patient's condition to improve.
Timeline
- Start
- 2004-07
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Spironolactone | Small molecule | 25 mg | — |